"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Hold on to your huaraches: as ...

If you have a mini vacation or bachelorette on the horizon and want something new and splashy to get you there in style, Disney Store’s newest Lilly Pulitzer markdown arrived just in time.

"Slim Aarons: Gold Coast," an exhibition that highlights Aarons' years of work in Palm Beach and how that work intertwined with Palm Beach icon Lilly Pulitzer, kicks off the Ann Norton Sculpture ...

UPF 50+ Luxletic half-zip sunguard with a shirt-tail hem and shirring detail on the shoulders. 27 in length (based on a size small/4). Some colors are more vibrant in person. Please note: this style ...

Half-zip, long sleeve popover with a ruffled neckline, gold Lilly logo zipper pull, front welt pockets, and a rounded hem. Lounge Velour (94% Polyester, 6% Spandex). Machine wash cold, delicate cycle, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

RISES OVER 1.6% AT IT’S HIGH FOR THE DAY AFTER EARLY DROP AND THE POWER INFLOW SIGNAL Eli Lilly & Company LLY today ... along with size, timing, and other associated characteristics and patterns ...

Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

Oct 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. J&J evaluated its Tremfya in patients with low ...

Eli Lilly has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC ...